content top

Early vs Late Treatment of ME Due to BRVO with Either Ranibizumab or Bevacizumab

SCIENTIFIC POSTER_Sezin Ozdogan Erkul_1 In this study we wanted to compare efficacy and safety of bevacizumab and ranibizumab in treatment of macular edema due to branch retinal vein occlusion depending on the duration of macular edema. An institutional review board approved retrospective survey was done among 58 eyes of 57 patients having macular edema due to branch retinal vein occlusion. Patients were grouped according to the initial...

Read More

The Availability of 24-hour Ambulatory Blood Pressure Monitoring in the BRVO

Poster Il Han Yun Purpose: Hypertension is a major risk factor of retinal vascular occlusion. Generally, blood pressure (BP) has a tendency of fluctuation increased with activity and decreased at night or rest. Especially, non-dipper status is thought to be of clinical and prognostic relevance to target organ damage (TOD) in many studies. So we took part in a measure the 24-hour ambulatory blood pressure monitoring (24hour ABPM) in...

Read More

3 Bevacizumab vs 2 Triamcinolone Injections in Recent BRVO

Advantages: Repeated intravitreal injections of bevacizumab (IVB) are more efficacious than repeated intravitreal injections of triamcinolone (IVT) in the treatment of macular edema in acute branch retinal vein occlusion (BRVO).

Read More

Comparison of Triamcinolone vs Bevacizumab Combined with Grid Laser in ME Due to BRVO

Advantages: To compare the effectiveness of intravitreal triamcinolone and bevacizumab injections combined with grid laser photocoagulation for macular edema due to branch retinal vein occlusion. Methods: Retrospective, comparative, interventional clinical study. 37 patients with macular edema due to branch retinal vein occlusion treated with intravitreal triamcinolone acetonide injection combined with grid laser photocoagulation and 18...

Read More

Why Use the Pascal Laser to Treat Retinal Vascular Ischemic Pathologies and Macular Edemas?

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Catherine Favard (Paris, France) Advantages: The Pattern Scanning Laser (Pascal) is a semi-automatic photocoagulator using short pulses of 10 to 20 milliseconds applied in square (2X2 to 5X5 impacts) or grid (14 to 56 impacts) patterns. Methods: Between March 2008 and May 2010, 27 eyes: 15 Ischemic diabetic retinopathies (DR) and 12...

Read More

Combined Treatment of CME after Branch Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Ivan Fiser, Martina Rubesova (Prague, Czech Republic) Advantages: In most cases of persisting CME after BRVO we use vitrectomy with ILM peeling which has a good effect in more than 60 % of eyes but. In some patients we start with Avastin that brings a repeated benefit but later recurrences of CME happen. Laser coagulation in edematous...

Read More

Combined Treatment of CME after Central Retinal Vein Occlusion

Ivan Fiser, Martina Rubesova (Prague, Czech Republic) Advantages: CME after CRVO is a typical case where it is very difficult to define which treatment is best to start with. Triamcinolone can be helpful (which was shown in a recent study) but a recurrence can happen. Avastin also has a temporary effect. ILM peeling can be beneficial, too, but we also see recurrences of CME after it. Laser treatment of edematous retina is difficult. We...

Read More

Central Retinal Vein Occlusion / Branch Retinal Vein Occlusion: It is More Brilliant to Peel the ILM

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Didier Ducournau (Nantes, France) Last year, during the 2009 EVRS congress, we presented the results of ILM removal on 236 patients presented a macular edema after BRVO (82) and CRVO 154); more than one year after operation, the obtained improvement (in LorMAR lines) was superior to 5 lines i.e. twice as much than after repeated...

Read More

ILM Peeling in Branch Retinal Vein Occlusion & Central Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Jean-Paul Amar (Cannes, France) The author made a study on 130 cases over 3 years. The results confirmed those presented last year by Didier Ducournau. The removal of the ILM demonstrates a long-term improvement of visual acuity and a nearly total disappearance of neovascular glaucoma. The importance of the improvement is higher than the...

Read More

Three-Intravitreal Bevacizumab vs Two-Intravitreal Triamcinolone Injections in Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Alireza Ramezani, Morteza Entezari, Siamak Moradian, Hamed Esfandiari, Babak Dehsarvi, Masoud Soheilian, Hamid Ahmadieh, Mehdi Yaseri (Tehran, Iran) Advantages: Repeated intravitreal injections of bevacizumab (IVB) are more effective than repeated intravitreal injections of triamcinolone (IVT) in acute retinal vein occlusion...

Read More

Intravitreal Bevacizumab vs Sham Treatment in Acute Branch Retinal Vein Occlusion with Macular Edema: Short Term Results (Report 1)

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Siamak Moradian, Hooshang Faghihi, Babak Sadeghi, Niloofar Piri, Hamid Ahmadieh, Masoud Soheilian, Mohammad Hossein Dehghan, Mohsen Azarmina, Mohammad Riazi Esfahani (Tehran, Iran) Advantages: To compare the visual and anatomical (central macular thickness; CMT) outcomes of intravitreal bevacizumab (IVB) injections relative to sham...

Read More

Intravitreal Injection of Bevacizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Salim Ben Yahia, Riadh Messaoud, Imen Chtioui, Rim Kahloun, Sonia Zaouali, Moncef Khairallah (Monastir, Tunisia) Advantages: To manage macular edema secondary to retinal vein occlusion with intravitreal injection of bevacizumab. Methods: Thirty eyes of 30 patients with macular edema secondary to retinal vein occlusion (central retinal...

Read More

Examination of the Relation Between Clinic, Fluorescein Angiographic Findings and Ophthalmodynamometric Measurements in Patients with Central Retinal Vein Obstruction

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Hülya Güngel (Istanbul, Turkey) Advantages: To examine the relation between clinic, fluorescein angiographic findings and ophthalmodynamometric measurements in patients with central retinal vein obstruction. Methods: Routine ophthalmologic examination, fluorescein angiography and ophthalmodynometry was performed in 28 subjects. H.K....

Read More

Intravitreal Growth Factors in Central Retinal Vein Occlusion and Branch Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Michael Koss, M. Pfister, F. Rothweiler, M.  Michaelis, J.  Cinati, Pankaj Singh, Frank Koch (Frankfurt am Main, Germany) Advantages: To determine the levels of intravitreal VEGF A, monocytic adhesion protein = MCP, and IL-6 levels in retinal vein obstruction over a clinical observation time. Methods: Twelve patients with central...

Read More

Intravitreal Triamcinolone and Bevacizumab Injection for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion

Kubilhan Elmas, Özgür Bilen, Ali Altýnsoy (Ankara, Turkey) Purpose: To evaluate the efficacy of intravitreal triamcinolone injection in eyes with macular edema due to branch retinal vein occlusion (BRVO) over a 1-year period. Methods: The authors performed a retrospective chart review of 18 eyes of 18 patients (mean age 71 years) who underwent intravitreal injections with 2 mg triamcinolone acetonide and 1,25 mg bevacizumab for macular...

Read More

Macular Demain Branch Retinal Vein Occlusion: Early Treatment Using Laser Arteriolar Constriction Yiels Good Results

http://www.evrs.eu/medias/2009/congress/Which-Laser.flv Authors: Jiri Rehak, Barbora Babkova, Zuzana Pracharova, Martin Sin, Matus Rehak,  Olomouc, Czech Republic Advantages: Determination of prognostically unfavourable branch retinal vein occlusion (BRVO) using initial visual acuity (VA) is a very simple and valuable procedure, which can be done by the general practitioner. The laser arteriolar constriction technique could be successfully...

Read More

Effects of Anti-VEGF Therapy versus Triamcinolone Intravitreal Injection on Non Ischemin Macular Edema of BRVO

Authors: Dong Hyun Jee, Sang Hee Doh, Suwon City, Kyoungki Province, South Korea Advantages: Effects of intrvitreal ranibizumab injection are more efficient than intravitreal triamcinolone injection on non-ischemic macular edema of BRVO. Methods: In a prospective randomised clinical trial, 50 eyes of 50 patients with non-ischemic macular edema of BRVO were included. Eligible eyes were assigned to 0.05mg ranibizumab(25 eyes) or 0.05cc...

Read More

Changes of Aqueous Vascular Endothelial Growth Factor and Pigment Pithelium-Derived Factor Following Intravitreal Bevacizumab for Macular Oedema Secondary to Branch Retinal Vein Occlusion

Authors: Sung Pyo Park, Jae Kyoun Ahn, South Korea Advantages / Purpose: To investigate sequential changes of aqueous vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in macular oedema secondary to branch retinal vein occlusion (BRVO) following intravitreal injection of bevacizumab (IVB). Methods: We recruited ten healthy controls and forty patients with BRVO. Aqueous levels of VEGF and PEDF were...

Read More

Intravitreal Ranibizumab (Lucentis) for Branch Retinal Vein Occlusion Induced Macular Edema: 6 Months Results of a Prospective Study

Authors: Petros Petrou , Alexander Rouvas, Amalia Ntouraki, Ioannis Ladas, Ioannis Vergados, Athens, Greece Background/Purpose: To evaluate the effect of individualized repeated intravitreal injections of ranibizumab (Lucentis) on visual acuity (VA) and central foveal thickness (CFT) for branch retinal vein occlusion (BRVO)-induced macular edema. Methods: Our study was a prospective interventional case series. 28 eyes of 28 consecutive...

Read More

Combined 25g Vitrectomy + Sheathatomy + ILM Peeling + Phacoemulsification + IOL Implantation for the Treatment ofBranch Retinal Vein Occlusion

Murat Oncel, MD (Istanbul, Turkey) SYNOPSIS This film demonstrates the use of the transcon-junctival sutureless 25-gauge vitrectomy system combining with clear corneal phacoemulsification and posterior chamber intraocular lens implantation. Sheathotomy was performed either using a special knife or nitinol flexiable extandible pick with trypan blue-assisted peeling of the internal limiting membrane in branch retinal vein occlusion. Pre- and...

Read More

Intravitreal Bevacizumab for Treatment of Macular Edema in Central and Branch Retinal Vein Occlusion

Ajay Dudani, MD (Mumbai, India), Alay S Banker, MD (Ahmedabad, Gujarat, India), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela) PURPOSE: To report the anatomic and visual acuity response after intravitreal injection of bevacizumab in patients with macular edema due to central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). METHODS: Prospective study of patients with macular edema due to CRVO/BRVO who were treated...

Read More

Macular Edema in Branch Retinal Vein Occlusion (BRVO) – Early Treatment with Laser Arteriolar Constriction Technique. New Approach

http://www.evrs.eu/medias/2005/congress/Macular-Edema-in-Branch-Retinal-Vein-Occlusion-(BRVO)-Early-Treatment-with-Laser-Arteriolar-Constriction-Technique.-New-Approach.swf Jiri Rehak, Barbora Babkova, Zuzana Pracharova, Evzen Fric Department of Ophthalmology, Palacky University, Olomouc, Czech Republic Purpose: To evaluate the effects of laser arteriolar constriction technique in combination with medicamentous therapy on visual acuity (VA)...

Read More

Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion. New Approach.

http://www.evrs.eu/medias/2005/congress/Pathogenesis-of-Macular-Edema-in-Branch-Retinal-Vein-Occlusion.-New Approach.swf Jiri Rehak – Department of Ophthalmology, Palacky University, Olomouc, Czech Republic Purpose: The study of pathogenesis of circulatory disturbances in branch retinal vein occlusion (BRVO) was based on our conviction that better understanding of this problem could be useful in the therapy of this frequent and severe...

Read More
content top